how frontline therapy impacts the management of patients with all prior to car-t
Published 6 months ago • 48 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
1:53
the detection and management of mnts following bcma-directed car-t therapy
-
3:07
the role of bridging and timing in car-t
-
3:43
the future of car-t therapy
-
1:43
management of car-t related side effects
-
1:36
the future of frontline treatment in all: immunotherapy
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
1:38
challenges of car-t therapy in the real-world setting
-
0:48
asciminib for the treatment of cml
-
41:39
2022 wmif | the cell therapy landscape | car-t to stem cells
-
3:14
car t-cell therapy explained (manufacturing process & how it works)
-
3:58
manufacturing car t cells to accelerate cancer immunotherapy research
-
1:04
the major hurdles and emerging opportunities of car t-cell therapy
-
3:03
the impact of salvage and bridging therapy on car t-cell therapy outcomes in b-all: an itt analysis
-
1:26
impact of recent bendamustine treatment before apheresis on car-t therapy outcomes in lbcl
-
1:55
exploring first-line car-t therapy for the treatment of dlbcl
-
3:33
an overview of the car t-cell therapy story
-
1:16
car-t treatment journey and the role of the nurse
-
1:49
a novel subcutaneous car-t therapy for the treatment of hematological malignancies
-
4:10
car t-cell therapy for all
-
0:51
car-t as a frontline standard of care in all?
-
2:10
optimizing car-t therapy in lbcl